RxDoctor Payments Data

Jeffrey Stimac, MD

Orthopaedic Surgery · Louisville, KYNPI 1225241060

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $22,629 of the $32,679 with a category attached, or 69.2%. 12 manufacturers reported payments, led by Medical Device Business Services, Inc. at 49.0% of the total. Reporting peaked in 2020 at $12,715 and has fallen 73.8% since, to $3,333 in 2025.

$32,679in general payments, 2019–2025

Across 77 payments — averaging $424.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$16K
  • Zimmer Biomet$10K
  • Depuy Synthes Products, Inc.$6K
  • Johnson & Johnson$249
  • Osteoremedies, LLC$156
  • Medacta USA, Inc.$147
  • plus $342 from 6 others
$13,389in research payments, 2019–2025

Across 2 payments — averaging $6694.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$13K

What the payments were for

  • Consulting fees$22,62969%
  • Travel & lodging$4,52214%
  • Food & beverage$5,52817%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,679 in reported general payments places this provider in the 80th percentile of 322 orthopaedic surgery providers in Kentucky.

See all orthopaedic surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$195,670
Medicare patients
367
Services billed
2,808

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AmantadineAmantadine Hcl12$1,857
Celecoxib30$1,410
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen140$1,161
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen68$608
Meloxicam144$602
Ondansetron Hcl104$511
Mupirocin87$495
Cephalexin85$300
Methylprednisolone29$179
Gabapentin22$71
Tramadol Hcl26$50

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Louisville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →